Skip to main content
Watch Insiders

Institutional filer profile

OrbiMed Capital GP VII LLC Insider Trades

Latest reported as Corporate insider of ADARx Pharmaceuticals, Inc. (ADRX).

Purchase filings
3
Reported companies
4
Net open-market value
-$533,054.28
Latest transaction
Sep 28, 2026

Affiliated corporations

Reported company relationships

ADRXLatest reported

ADARx Pharmaceuticals, Inc.

Corporate insider

ETRAPrior filing

Electra Therapeutics, Inc.

Corporate insider

ELVNPrior filing

Enliven Therapeutics, Inc.

Corporate insider

QTTBPrior filing

Q32 Bio Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 28, 2026ADARx Pharmaceuticals, Inc. (ADRX)Corporate insiderOpen Market Purchase950,000$17.00$16,150,000
Sep 21, 2026Electra Therapeutics, Inc. (ETRA)Corporate insiderOpen Market Purchase1,333,333$15.00$19,999,995
Jun 22, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale860,123$45.36$39,014,061
Jun 15, 2026Enliven Therapeutics, Inc. (ELVN)Corporate insiderSale281,408$45.02$12,668,988
May 28, 2026Q32 Bio Inc. (QTTB)Corporate insiderOpen Market Purchase1,875,000$8.00$15,000,000